Glaukos (GKOS) Depreciation & Amortization (CF) (2014 - 2026)
Glaukos (GKOS) posted quarterly Depreciation & Amortization (CF) of $8.9 million for Q2 2026, up 3.51% year-over-year from $8.6 million in Q2 2025, and down 24.81% quarter-over-quarter from $11.8 million in Q1 2026.
Glaukos (GKOS) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Depreciation & Amortization (CF) for 13 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 3.51% year-over-year to $8.9 million; the TTM figure through Jun 2026 stood at $42.0 million (up 21.51% YoY), while the FY2025 annual figure was $38.1 million, up 6.85% from the prior year.
- Depreciation & Amortization (CF) declined to $8.9 million in Q2 2026 per GKOS's latest filing, from $11.8 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $26.9 million in Q4 2022 and bottomed at $1.4 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $7.5 million across 5 years, with a median of $8.7 million in 2024.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) slumped 91.49% — and 2024, when it soared 328.92%.
- Glaukos' Depreciation & Amortization (CF) stood at $26.9 million in 2022, then plunged by 91.49% to $2.3 million in 2023, then jumped by 282.16% to $8.7 million in 2024, then soared by 39.18% to $12.2 million in 2025, then decreased by 27.08% to $8.9 million in 2026.
- Business Quant data shows GKOS's Depreciation & Amortization (CF) at $8.9 million in Q2 2026, $11.8 million in Q1 2026, and $12.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Glaukos | 10.81 Bn | 10.70 Bn | 151.59 Mn | 8.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.87 Mn |
| Jun 30, 2026 | 8.87 Mn |
| Mar 31, 2026 | 11.80 Mn |
| Mar 31, 2026 | 11.80 Mn |
| Dec 31, 2025 | 12.16 Mn |
| Dec 31, 2025 | 12.16 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Jun 30, 2025 | 8.57 Mn |
| Jun 30, 2025 | 8.57 Mn |
| Mar 31, 2025 | 8.23 Mn |
| Mar 31, 2025 | 8.23 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 8.91 Mn |
| Mar 31, 2024 | 8.91 Mn |